Regenerative

Stem Cell Therapy

The foundation of ARDIG's regenerative medicine programs.

Mesenchymal stem cell (MSC) therapy uses the body's own regenerative mechanisms to repair tissue, modulate the immune system, and reduce inflammation. ARDIG applies this technology across multiple conditions with physician-designed, individualized protocols.

How ARDIG Applies Stem Cell Therapy

Our approach goes beyond a single injection. Every protocol is built around the patient's specific condition, severity, and goals.

Source & Quality

We have worked with certified tissue banks for over 15 years, using rigorously tested, ethically sourced mesenchymal stem cells with full chain-of-custody documentation. When appropriate, we also use autologous stem cells from the patient's own bone marrow.

Delivery Methods

Depending on the condition, cells are administered intravenously (IV) or intra-arterially to maximize therapeutic impact.

Dosing & Protocol

Cell count, number of sessions, and complementary therapies are all customized to each patient's condition and goals. Plan to be in-country for approximately 5 days — arriving the day before, treatment day, and 3 follow-up days. Patients arrange their own travel and accommodation.

Am I a Candidate?

Stem cell therapy may be appropriate if you meet certain criteria. Our medical team evaluates each case individually.

  • Diagnosed with a condition ARDIG treats such as autism, DMD, heart failure, MS, autoimmune conditions, and others
  • Living with a condition that has not responded adequately to conventional treatments
  • Have tried conventional therapies or are seeking complementary regenerative options
  • Willing to commit to the recommended follow-up and monitoring program

Important Note

Not everyone is a candidate. Factors such as active infection, certain cancers, or severe organ failure may disqualify patients. Our physicians will give you an honest assessment.

Get Evaluated

What to Expect

From your first consultation to ongoing follow-up, here is what the ARDIG journey looks like.

1

Free Consultation

Schedule a no-obligation call with one of our physicians to discuss your condition and treatment options.

2

Medical Evaluation

Our medical team reviews your records and determines if you are a candidate for our programs.

3

Schedule & Treatment

After medical evaluation and approval, choose your preferred treatment date and travel to one of our facilities for your scheduled treatment program.

4

Ongoing Care

After returning home, your ARDIG physician monitors your progress through scheduled telehealth appointments.

Risks & Limitations

Transparency is a core ARDIG value. We believe every patient deserves to understand both the potential benefits and the limitations of any treatment.

General Risks

As with any medical procedure, stem cell therapy carries risks including infection at injection sites, temporary fever, headache, and in rare cases allergic reactions. With over 20 years of experience, ARDIG minimizes these through sterile protocols and physician oversight.

Current Limitations

Stem cell therapy is not a cure. While many patients experience meaningful improvements, the degree and duration of benefit vary. Regenerative medicine is an evolving field and large-scale Phase III clinical trials for many conditions are still ongoing.

Results vary by patient. Regenerative medicine is an evolving field and outcomes cannot be guaranteed. Consult with our physicians for a realistic assessment.

FAQ

ARDIG primarily uses mesenchymal stem cells (MSCs) sourced from certified tissue banks we have partnered with for over 15 years. When appropriate, we also use the patient's own bone marrow-derived stem cells. All cells are rigorously tested for safety, viability, and potency before being used in any patient protocol.

Cell dosing depends on your condition, body weight, and treatment protocol. Typical doses range from tens of millions to hundreds of millions of cells, customized to each patient.

Most patients report minimal discomfort. Intravenous infusions feel similar to a typical IV drip. Intra-arterial administration is a minimally invasive procedure. For pediatric patients, IV administration is the standard approach.

Timelines vary by condition. Some patients notice improvements within weeks, while others see gradual changes over 3-6 months. Our follow-up program tracks progress at regular intervals.

Your physician will recommend a treatment schedule based on your individual response and therapeutic goals.

ARDIG operates in Mexico, Peru, and the United States. Stem cell therapy is considered an experimental treatment and is not FDA-approved in the US for most conditions. MSC therapy is the subject of extensive clinical research worldwide and is legally practiced under medical supervision in our operating countries.

Reach us

We reply within 24 hours Your information is private and secure